Search Results for 'top 20 pharma companies'

Search For:
Refine by Dates:
From: To:
Refine By Content:

  • Capsules
    2008 Top 20 Pharma Companies

    2008 Top 20 Pharma Companies

    The weak U.S. dollar played a strong role in this year’s Top 20 Pharma Report. Several overseas players look a lot better than they should, thanks to my insistence on converting all results to dollars. In local currencies, many foreign and domestic players were barely able to eke out growth in 2007.
    07.19.12

  • Capsules
    2009 Top 20 Pharma Companies

    2009 Top 20 Pharma Companies

    They don’t call them “Big Pharma” for nothing! Several of the industry’s biggest players decided to get bigger via M&A this year, which means next year’s ranks are going to feature at least three new players, once Wyeth and Schering-Plough are swallowed up and Roche moves over to the Top Biopharma ranks. And I do mean top!
    07.19.12

  • Capsules
    2010 Top 20 Pharma Companies

  • Capsules
    2011 Top 20 Pharma Companies

    2011 Top 20 Pharma Companies

    Our annual look at the biggest companies in the pharma industry
    07.19.12

  • Research

    Research

    Whether you're looking for the latest whitepapers or our industry-leading Top Companies reports and surveys, the categories below offer some of the most valuable information around.
    02.28.11

  • R&D

    Tops at Ten

    10 years of ranking pharma and biopharma
    Gil Y. Roth 07.09.10

  • Capsules
    2009 Top 10 Biopharmaceutical Companies Report

    2009 Top 10 Biopharmaceutical Companies Report

    This edition of the Top 10 Biopharmas marks the end of an era. After this year, we’ll no longer be able to pencil in Amgen as our #1 biopharma, since Roche is poised to take that slot. A lot of major pharmas have talked about “becoming a global biopharma.
    07.15.09

  • Capsules
    2008 Top 10 Biopharmaceutical Companies Report

    2008 Top 10 Biopharmaceutical Companies Report

    After years of producing this report, I’ve finally settled on definitive criteria for the Top Biopharma ranks! After consulting with Ronald A. Rader, president of the Biotechnology Information Institute, I decided that a Top Biopharma company is one that makes more than 40% of its drug revenues by selling biologic products, including biotherapeutics, vaccines and other proteins.
    07.18.08

  • From the Editor: It's All About Timing

    Market corrections abound
    Gil Roth 09.13.06

  • 2006 Top 20 Pharmaceutical Companies Report

    2006 Top 20 Pharmaceutical Companies Report

    Last year (our 2005 edition), Pfizer was 47% ahead of its closest competitor in drug revenues ($46 billion to $31 billion), but that margin was shaved to 30% in 2005 as Pfizer sales dropped 4%.
    07.18.06

  • Chemistry | Drug Discovery

    Top 20 Pharmaceutical Companies Report

    Our annual look at the 20 biggest players in the pharmaceutical marketplace
    08.23.05

Loading, Please Wait..